Comparing buccal midazolam vs. intravenous diazepam in control of acute seizures in children.
Not Applicable
- Conditions
- Acute childhood seizure.Epilepsy
- Registration Number
- IRCT138902293967N1
- Lead Sponsor
- Pediatric Neurology Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 92
Inclusion Criteria
all children aged 6 months to 14 years old presenting with acute generalized seizure in emergency ward or pediatric neurology ward are randomly assigned to receive buccal midazolam or intravenous diazepam.
Exclusion criteria: seizures due to head trauma or known metabolic causes (hypoglycemia, hypocalcemia)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The time it takes to control seizure. Timepoint: The time it takes to control seizure is measured once after using IV diazepam vs. buccal midazolam. Method of measurement: Time measured in minute, evaluated from start to the end of seizure.
- Secondary Outcome Measures
Name Time Method Potential side effects. Timepoint: Potential side effects of the two drugs. Method of measurement: Clinical evaluation of possible side effect.